NCT01007526View on ClinicalTrials.gov

Concomitant Chemo-radiotherapy Plus VIDL Chemotherapy in NK/T-cell Lymphoma

PHASE2CompletedINTERVENTIONAL
Enrollment

31

Participants

Timeline

Start Date

April 30, 2008

Primary Completion Date

December 31, 2012

Study Completion Date

December 31, 2012

Conditions
NK/T-cell Lymphoma of Nasal Cavity
Interventions
OTHER

CCRT followed by VIDL chemotherapy

CCRT followed by VIDL chemotherapy concomitant chemo-radiotherapy followed by VIDL (VP-16, Ifosfamide, Dexamethasone, L-asparaginase) chemotherapy with risk-based application of autologous stem cell transplantation

Trial Locations (1)

135-710

Samsung Medical Center, Seoul

Sponsors

Collaborators (1)

Asan Medical Center
All Listed Sponsors
collaborator

Asan Medical Center

OTHER

collaborator

National Cancer Center, Korea

OTHER_GOV

collaborator

Severance Hospital

OTHER

lead

Samsung Medical Center

OTHER